Stockscreener 앱 받기
9.22
1.21%
0.11
시장 영업 전:
9.18
-0.04
-0.43%
Organon Co 주식(OGN)의 최신 뉴스
Natixis Advisors LLC Has $778,000 Holdings in Organon & Co. (NYSE:OGN) - Defense World
Organon & Co. (OGN): Assessing Dividend Sustainability and Valuation Amid Earnings Pressures and Strategic Catalysts - AInvest
Read This Before Considering Organon & Co. (NYSE:OGN) For Its Upcoming US$0.02 Dividend - sg.finance.yahoo.com
Organon & Co. (OGN) Reports Q2 2025 Results - MSN
Organon Q2 Preview: What to expect? - MSN
Organon & Co. (NYSE:OGN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Organon & Co. (NYSE:OGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year - Yahoo Finance
Organon & Co. Earnings Call: Resilience Amid Challenges - The Globe and Mail
Organon (OGN) Fiscal Q2 Revenue Beats 1% - AOL.com
Organon & Co. (OGN) Slashes 13.13% on Disappointing Earnings - MSN
Organon Q2 Earnings: It May Be Time To Desert This Sinking Ship (Downgrade) (NYSE:OGN) - Seeking Alpha
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail
Organon & Co. SEC 10-Q Report - TradingView
Organon & Co. (NYSE:OGN) Q2 2025 Earnings Call Transcript - Insider Monkey
Organon Reports Results for the Second Quarter Ended June 30, 2025 - BioSpace
Organon & Co (OGN) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth By GuruFocus - Investing.com Canada
Organon & Co. Reports Q2 2025 Financial Results - TipRanks
Organon: Q2 Earnings Snapshot - Norwalk Hour
Organon raises 2025 revenue guidance by $100M amid Vtama ramp and debt reduction focus - MSN
Organon & Co To Go Ex-Dividend On August 15th, 2025 With 0.02 USD Dividend Per Share - 富途牛牛
Organon reports Q2 adjusted EPS $1.00, consensus 94c - TipRanks
Organon raises FY25 revenue view to $6.28B-$6.38B from $6.13B-$6.33B - TipRanks
OGN Shares Plunge: Lawsuit Drives Market Shock - StocksToTrade
Organon & Co. 2025 Q2ResultsEarnings Call Presentation (NYSE:OGN) - Seeking Alpha
Earnings call transcript: Organon Q2 2025 beats EPS expectations, stock volatile - Investing.com
Organon Becomes Oversold - Nasdaq
Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Organon & Co. Reports Strong Q2 Earnings, Surpassing ExpectationsNews and Statistics - IndexBox
Organon surpasses expectations with $1.59B revenue in Q2 2025 - grafa.com
Organon's Strategic Path to Financial Stability and Dividend Resumption - AInvest
Organon Q2 2025 slides: Revenue guidance raised amid Women’s Health strength - Investing.com Australia
Organon (OGN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Organon jumps despite Q2 revenue dip as revised outlook exceeds consensus - MSN
Organon Q2 Adjusted Earnings, Revenue Fall, Beat Estimates; 2025 Revenue Guidance Raised - MarketScreener
Organon stock jumps after Q2 revenue beat (OGN:NYSE) - Seeking Alpha
Organon (NYSE:OGN) Surprises With Q2 Sales, Stock Soars - Yahoo Finance
Organon shares surge over 8% as Q2 earnings top estimates, raises revenue outlook - Investing.com India
Organon Co earnings beat by $0.06, revenue topped estimates - Investing.com Australia
Earnings Snapshot: Organon new revenue outlook beats estimates after strong Q2 (OGN:NYSE) - Seeking Alpha
Organon in charts: Women's Health revenue up ~3% Y/Y in Q2 (NYSE:OGN) - Seeking Alpha
Organon Earnings: What To Look For From OGN - Yahoo Finance
Organon & Co. (OGN) Expected to Announce Earnings on Tuesday - Defense World
Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics - Yahoo Finance
Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
OGN’s Market Whiplash: -54.75% YTD Decline, 3.72% Rise in 30 Days - investchronicle.com
Organon adds mood tracking to Propecia app in Korea, with global rollout ahead - koreabiomed.com
Organon & Co (OGN.US) will release its Earnings Reports before the market opens on August 5th. - 富途牛牛
Can Analyst Optimism Outweigh Softer Earnings Expectations for Organon (OGN) This Quarter? - simplywall.st
Ramsay Health Care (OTCMKTS:RMYHY) vs. Organon & Co. (NYSE:OGN) Head to Head Contrast - Defense World
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Envestnet Asset Management Inc. Has $4.51 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World
0.63%
1.44%
자본화:
|
볼륨(24시간):